{Reference Type}: Journal Article
{Title}: Challenges of Multiplex Assays for COVID-19 Research: A Machine Learning Perspective.
{Author}: Guest PC;Popovic D;Steiner J;
{Journal}: Methods Mol Biol
{Volume}: 2511
{Issue}: 0
{Year}: 2022
暂无{DOI}: 10.1007/978-1-0716-2395-4_3
{Abstract}: Multiplex assays that provide simultaneous measurement of multiple analytes in biological samples have now developed into widely used technologies in the study of diseases, drug discovery, and other medical areas. These approaches span multiple assay systems and can provide readouts of specific assay components with similar accuracy as the respective single assay measurements. Multiplexing allows the consumption of lower sample volumes, lower costs, and higher throughput compared with carrying out single assays. A number of recent studies have demonstrated the impact of multiplex assays in the study of the SARS-CoV-2 virus, the infectious agent responsible for the current COVID-19 pandemic. In this respect, machine learning techniques have proven to be highly valuable in capturing complex disease phenotypes and converting these insights into models which can be applied in real-world settings. This chapter gives an overview of opportunities and challenges of multiplexed biomarker analysis, with a focus on the use of machine learning aimed at identification of biological signatures for increasing our understanding of COVID-19 disease, and for improved diagnostics and prediction of disease outcomes.